TWA
ANTH

TCI Wealth Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

TCI Wealth Advisors’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-375
Closed -$26K – 1043
2015
Q2 		$26K Buy
+375
New +$17.4K 0.01% 361

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

TCI Wealth Advisors's ANTH Position: Q3 2015 in Review

TCI Wealth Advisors sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2015, closing a stake of 375 shares — an estimated $26K sold.

TCI Wealth Advisors first reported a position in ANTH in Q2 2015 and held it in 1 quarter. The position peaked at $26K in Q2 2015. 86 funds tracked by Wall St. Rank hold ANTH as of Q3 2015.

  • TCI Wealth Advisors reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • TCI Wealth Advisors sold 375 Anthera Pharmaceuticals, Inc. shares in Q3 2015, an estimated $26K.
  • TCI Wealth Advisors first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • TCI Wealth Advisors's Anthera Pharmaceuticals, Inc. position peaked at $26K in Q2 2015.
  • 86 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2015.

Based on TCI Wealth Advisors's 13F filing for Q3 2015, filed 2 Nov 2015.